Hemcheck Sweden AB (publ) publishes the Annual Report for 2016 - Regulatory

hemCheck Publishes the Annual Report for 2016 - Regulatory

This Press Release should not be released or distributed, directly or indirectly, within USA, Canada, Japan, Australia, Hong Kong, Switzerland, Singapore, South Africa, New Zealand or any other jurisdictions where distribution would be subject to legal restrictions.

Hemcheck Sweden AB (publ) announces today that the company publishes the annual report for 2016. The annual report is available in Swedish on the company's website www.hemcheck.com and via the attached PDF.

About hemCheck:

Hemcheck Sweden is a medical technology company addressing the issue of hemolysis (the rupturing of red blood cells) - the most common reason for blood samples to be deemed unfit for laboratory analysis. Hemcheck Sweden is doing this by developing and commercializing a novel product concept (HELGE(TM) and READY(TM)) that detects hemolyzed blood samples at the point of care. Hemcheck Sweden was founded in 2010 and is headquartered in Karlstad, Sweden.

Contact
hemCheck Sweden AB (publ)
Annelie Brolinson, CEO
Tel: [phone]
E-post: [e-mail]
Universitetsgatan 2
651 88 Karlstad
www.hemcheck.com

Important information
This is information which hemCheck is required to disclose according to EU Market Abuse Regulation law. The information was provided by the above contact person's auspices, for publication on 28^th of April 2017, 09:00.

Annual Report 2016

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hemcheck Sweden AB via Globenewswire